
BAM15 15 mg + SLU-PP-332 250 mcg per tablet.
A combination tablet of BAM15 and SLU-PP-332, two compounds studied in metabolic and exercise-mimetic research. The box lists BAM15 15 mg and SLU-PP-332 250 mcg per tablet (15.25 mg total).
BAM15 is investigated for increasing mitochondrial energy use; SLU-PP-332 is investigated for activating oestrogen-related receptors involved in muscle energy metabolism.
Human safety data are not established. Not for use in pregnancy or breastfeeding, or by anyone under 18. Stop and seek medical care if you feel overheated, unwell or have a racing heart.
Follow the label on the box and discuss use with a qualified healthcare professional before starting. No dose is suggested here.
Follow the label on the box. Keep sealed, cool, dry and out of direct light and out of children’s reach. Ask for advice after any temperature excursion.
Tablets of BAM15 15 mg + SLU-PP-332 250 mcg, as listed on the box.
Do not self-stack research compounds, stimulants or hormone-active products. Ask a qualified clinician to review ingredients, medicines, medical history and monitoring requirements.
Contact Peak Protocol for the current batch’s identity, strength and purity documentation. No universal purity percentage or accreditation is assumed.
Contact us within 2 days with photo or video evidence. No product refunds: approved returns are for store credit only after inspection. Return courier costs are paid by the client. See the full returns policy.